Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

An investigation of retinal layer thicknesses in unaffected first-degree relatives of schizophrenia patients.

Kurtulmus A, Elbay A, Parlakkaya FB, Kilicarslan T, Ozdemir MH, Kirpinar I.

Schizophr Res. 2020 Jan 14. pii: S0920-9964(19)30604-8. doi: 10.1016/j.schres.2019.12.034. [Epub ahead of print]

PMID:
31948898
2.

Sialorrhoea associated with sertraline use.

Şahan E, Kılıçarslan T, Kırpınar İ.

Scott Med J. 2019 Nov;64(4):159-161. doi: 10.1177/0036933019875051. Epub 2019 Sep 10.

PMID:
31506028
3.

Designer drugs that are potent inhibitors of CYP2D6.

Pritzker D, Kanungo A, Kilicarslan T, Tyndale RF, Sellers EM.

J Clin Psychopharmacol. 2002 Jun;22(3):330-2.

PMID:
12006905
4.

Treatment of codeine dependence with inhibitors of cytochrome P450 2D6.

Fernandes LC, Kilicarslan T, Kaplan HL, Tyndale RF, Sellers EM, Romach MK.

J Clin Psychopharmacol. 2002 Jun;22(3):326-9.

PMID:
12006904
5.

Inhibition of cytochromes P450 by antifungal imidazole derivatives.

Zhang W, Ramamoorthy Y, Kilicarslan T, Nolte H, Tyndale RF, Sellers EM.

Drug Metab Dispos. 2002 Mar;30(3):314-8.

PMID:
11854151
6.

Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.

Zhang W, Kilicarslan T, Tyndale RF, Sellers EM.

Drug Metab Dispos. 2001 Jun;29(6):897-902.

PMID:
11353760
7.

Flunitrazepam metabolism by cytochrome P450S 2C19 and 3A4.

Kilicarslan T, Haining RL, Rettie AE, Busto U, Tyndale RF, Sellers EM.

Drug Metab Dispos. 2001 Apr;29(4 Pt 1):460-5.

PMID:
11259331
8.

Lack of interaction of buprenorphine with flunitrazepam metabolism.

Kilicarslan T, Sellers EM.

Am J Psychiatry. 2000 Jul;157(7):1164-6.

PMID:
10873929

Supplemental Content

Loading ...
Support Center